Your browser doesn't support javascript.
loading
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease.
Momen, Sophie; Fassihi, Hiva; Davies, Helen R; Nikolaou, Christos; Degasperi, Andrea; Stefanato, Catherine M; Dias, Joao M L; Dasgupta, Dhruba; Craythorne, Emma; Sarkany, Robert; Papa, Sophie; Nik-Zainal, Serena.
Afiliação
  • Momen S; Department of Medical Genetics, Addenbrooke's Treatment Centre, The Clinical School, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, United Kingdom.
  • Fassihi H; National Xeroderma Pigmentosum Service, Department of Photodermatology, St John's Institute of Dermatology, Guy's and St Thomas' Foundation Trust, London SE1 7EH, United Kingdom.
  • Davies HR; National Xeroderma Pigmentosum Service, Department of Photodermatology, St John's Institute of Dermatology, Guy's and St Thomas' Foundation Trust, London SE1 7EH, United Kingdom.
  • Nikolaou C; Department of Medical Genetics, Addenbrooke's Treatment Centre, The Clinical School, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, United Kingdom.
  • Degasperi A; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, United Kingdom.
  • Stefanato CM; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, United Kingdom.
  • Dias JML; Department of Medical Genetics, Addenbrooke's Treatment Centre, The Clinical School, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, United Kingdom.
  • Dasgupta D; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, United Kingdom.
  • Craythorne E; Department of Dermatopathology, St John's Institute of Dermatology, Guy's and St Thomas' Foundation Trust, London SE1 7EH, United Kingdom.
  • Sarkany R; Department of Medical Genetics, Addenbrooke's Treatment Centre, The Clinical School, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, United Kingdom.
  • Papa S; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, United Kingdom.
  • Nik-Zainal S; Department of Nuclear Medicine, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, United Kingdom.
Cold Spring Harb Mol Case Stud ; 5(5)2019 10.
Article em En | MEDLINE | ID: mdl-31645345
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Xeroderma Pigmentoso / Hemangiossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Cold Spring Harb Mol Case Stud Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Xeroderma Pigmentoso / Hemangiossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Cold Spring Harb Mol Case Stud Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido